Stratos Wealth Partners LTD. reduced its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 6.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 33,069 shares of the pharmacy operator’s stock after selling 2,219 shares during the period. Stratos Wealth Partners LTD.’s holdings in Walgreens Boots Alliance were worth $2,746,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Wellington Management Group LLP increased its position in Walgreens Boots Alliance by 5.9% in the first quarter. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator’s stock valued at $2,727,932,000 after buying an additional 1,824,300 shares during the period. Nordea Investment Management AB increased its position in Walgreens Boots Alliance by 26.5% in the first quarter. Nordea Investment Management AB now owns 9,154,328 shares of the pharmacy operator’s stock valued at $760,267,000 after buying an additional 1,917,082 shares during the period. UBS Asset Management Americas Inc. increased its position in Walgreens Boots Alliance by 22.9% in the first quarter. UBS Asset Management Americas Inc. now owns 4,912,489 shares of the pharmacy operator’s stock valued at $407,982,000 after buying an additional 914,888 shares during the period. Swiss National Bank increased its position in Walgreens Boots Alliance by 27.3% in the first quarter. Swiss National Bank now owns 3,262,703 shares of the pharmacy operator’s stock valued at $270,967,000 after buying an additional 700,400 shares during the period. Finally, Schroder Investment Management Group increased its position in Walgreens Boots Alliance by 17.1% in the first quarter. Schroder Investment Management Group now owns 2,588,887 shares of the pharmacy operator’s stock valued at $215,681,000 after buying an additional 378,686 shares during the period. Institutional investors and hedge funds own 60.17% of the company’s stock.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ WBA) traded up 0.58% on Tuesday, reaching $81.63. The company had a trading volume of 631,251 shares. The firm has a market capitalization of $87.35 billion, a PE ratio of 20.61 and a beta of 1.25. The company has a 50-day moving average price of $79.95 and a 200-day moving average price of $82.28. Walgreens Boots Alliance, Inc. has a 52-week low of $75.18 and a 52-week high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.30 by $0.03. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The business had revenue of $30.12 billion during the quarter, compared to the consensus estimate of $29.72 billion. During the same period last year, the business posted $1.18 EPS. Walgreens Boots Alliance’s revenue was up 2.1% on a year-over-year basis. Equities research analysts forecast that Walgreens Boots Alliance, Inc. will post $5.00 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 12th. Shareholders of record on Friday, August 18th will be issued a $0.40 dividend. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. This represents a $1.60 annualized dividend and a yield of 1.97%. The ex-dividend date is Wednesday, August 16th. Walgreens Boots Alliance’s dividend payout ratio is currently 40.30%.

Walgreens Boots Alliance declared that its board has authorized a stock buyback plan on Thursday, June 29th that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the pharmacy operator to repurchase up to 5.9% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s leadership believes its shares are undervalued.

WARNING: “Stratos Wealth Partners LTD. Sells 2,219 Shares of Walgreens Boots Alliance, Inc. (WBA)” was published by Watch List News and is the property of of Watch List News. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international copyright and trademark law. The legal version of this report can be viewed at https://www.watchlistnews.com/stratos-wealth-partners-ltd-sells-2219-shares-of-walgreens-boots-alliance-inc-wba/1529729.html.

Several equities analysts recently weighed in on the company. Needham & Company LLC set a $94.00 target price on Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Monday, July 17th. Pivotal Research set a $85.00 target price on Walgreens Boots Alliance and gave the stock a “hold” rating in a research report on Sunday, July 2nd. Guggenheim reiterated a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Goldman Sachs Group, Inc. (The) reiterated a “neutral” rating and set a $77.00 target price (down from $89.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, June 28th. Finally, Morgan Stanley reiterated an “overweight” rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and fifteen have issued a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $91.06.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the stock in a transaction dated Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total value of $218,305.44. Following the transaction, the director now directly owns 19,151 shares of the company’s stock, valued at approximately $1,528,058.29. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 13.50% of the stock is owned by corporate insiders.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.